Table of Contents Table of Contents
Previous Page  28 / 61 Next Page
Information
Show Menu
Previous Page 28 / 61 Next Page
Page Background

OS by PD-L1 Expression

1.

1. Paz-Ares L et al.; J Clin Oncol 33, 2015 (suppl; abstr LBA109

)

Checkmate 057 – Biomarker-Analysis: OS benefit in the ITT population

in PD-L1 expressing tumors